Banque Pictet & Cie’s NuVasive, Inc. NUVA Stock Holding History

Banque Pictet & Cie’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,000	Closed	-$615K	–	376
2017 Q2	$615K	Buy	+8,000	New	+$598K	0.01%	280

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Banque Pictet & Cie's NUVA Position: Q3 2017 in Review

Banque Pictet & Cie sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 8,000 shares — an estimated $615K sold.

Banque Pictet & Cie first reported a position in NUVA in Q2 2017 and held it in 1 quarter. The position peaked at $615K in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

Banque Pictet & Cie reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
Banque Pictet & Cie sold 8,000 NuVasive, Inc. shares in Q3 2017, an estimated $615K.
Banque Pictet & Cie first reported a position in NuVasive, Inc. in Q2 2017 and held it in 1 quarter.
Banque Pictet & Cie's NuVasive, Inc. position peaked at $615K in Q2 2017.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Banque Pictet & Cie's 13F filing for Q3 2017, filed 7 Nov 2017.